A Special Thank You To Our Bronze Sponsor

The videos are listed according to the schedule

To see review the schedule click here.

2021 VIS – Day 1

Thierry Passeron, MD, PhD

Invited Speaker: Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study

Hyun Jeong Ju, MD

Progressive and Extensive Hypomelanosis of Childhood: A Novel Disease Entity Distinguished from Other Hypomelanotic Disorders

Marcella Willemsen, MSc

Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in Peripheral Blood of Segmental and Non-segmental Vitiligo Patients

Nanja van Geel, MD, PhD and Jolien Duponselle, MD

Image Analyses Systems to Calculate the Surface Area of Vitiligo Lesions: A Systematic Review of Measurement Properties

Caroline Le Poole, PhD

Invited Speaker: Modeling Microbial Impact on Autoimmune Depigmentation in Mice

2021 VIS – Day 2

David Rosmarin, MD

Invited Speaker: Efficacy and Safety of Ruxolitinib Cream for the Treatment of Vitiligo: 24-Week Results From 2 Randomized, Double-Blind Phase 3 Studies

Prashant Giri, MSc

Altered Calcium-NFAT Signaling Pathway May Be Responsible for Decreased Suppressive Capacity of Tregs in Generalized Vitiligo Patients

Janice Nathalie, MD

/
1 Comment
Health-Related Quality of Life in Pediatric Patients With Vitiligo

Thierry Passeron, MD, PhD Oral Abstract

Increased Cutaneous Activation of Innate Immunity and Pro-apoptotic CXCR3B in Patients With Segmental Vitiligo

Davinder Parsad, MD

Invited Speaker: Stabilizing Treatment Options in Vitiligo